ConductScience.org, home

Paper35797481

The 2022 hormone therapy position statement of The North American Menopause Society.

“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. Menopause, 2022. Cited by 735 papers, by iCite.

Cite this record

ConductScience Library. The 2022 hormone therapy position statement of The North American Menopause Society. Papers, record 35797481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35797481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The 2022 hormone therapy position statement of The North American Menopause Society.
PubMed
Journal
Menopause
PubMed
Year
2022
PubMed
Publication types
Journal Article, Consensus Statement
PubMed
Citations, by iCite
735
iCite
Relative citation ratio, by iCite
78.2
iCite
Revised in PubMed
2026-05-18
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory PanelGroup

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Estrogen Replacement TherapyMajor topic
MenopauseMajor topic
Estrogens
Female
Humans
North America
Progestins
Risk Assessment

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06357442Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.BackgroundClinicalTrials.gov
NCT06975111Focusing on the Menopausal Transition to Improve Mid-Life Women's HealthBackgroundClinicalTrials.gov

Download CSV of trials

Cited by316

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 735 citations.

PMIDTitleJournalYearIn PapersSource
42964149From menarche to menopause: a lifespan perspective on women's health in sickle cell disease.Front Epidemiol2026https://conductscience.org/library/papers/42964149PubMed
42960442Hormonal remodeling and molecular mechanisms in postmenopausal osteoporosis: Pathogenesis and therapeutic implications (Review).Int J Mol Med2026https://conductscience.org/library/papers/42960442PubMed
42948344
Burden, Risk Factors, and Temporal Trends of Ovarian Cancer in Postmenopausal Women Aged 55 Years and Older: A Comparative Analysis in India, China, and the United States Based on the Global Burden of Disease Study 2023.
Int J Womens Health2026https://conductscience.org/library/papers/42948344PubMed
42942900The Gut Microbiome-Estrogen Axis in Menopause: Implications for Body Composition, Cardiometabolic Health and Nutrition.Nutrients2026https://conductscience.org/library/papers/42942900PubMed
42942573The Interplay Between Oophorectomy and Alzheimer's Disease: A Narrative Review.Medicina (Kaunas)2026https://conductscience.org/library/papers/42942573PubMed
42941448Salivary Flow, Biochemical Profile and Selected Antibacterial Properties of Saliva in Menopausal Women.J Clin Med2026https://conductscience.org/library/papers/42941448PubMed
42941201Effects of Aerobic Exercise on Endogenous Estrogens and Body Composition in Women with Overweight or Obesity: A Systematic Review and Meta-Analysis.Metabolites2026https://conductscience.org/library/papers/42941201PubMed
42926595Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial.medRxiv2026https://conductscience.org/library/papers/42926595PubMed
42925072Menopause Literacy Gaps Across Individual, Healthcare and Societal Levels: A Qualitative Study of Women's Experiences and Healthcare Providers' Perspectives.Health Expect2026https://conductscience.org/library/papers/42925072PubMed
42923654Endometriosis-associated lesions during or after long-term estrogen-only therapy following hysterectomy: 2 cases.JCEM Case Rep2026https://conductscience.org/library/papers/42923654PubMed
42923369Safety and tolerability of elinzanetant: a pooled analysis from four randomized clinical trials.EClinicalMedicine2026https://conductscience.org/library/papers/42923369PubMed
42903646Patient-Centered menopause health management and menopausal hormone therapy uptake: A real-world study from a tertiary Hospital in China.Prev Med Rep2026https://conductscience.org/library/papers/42903646PubMed
42890743Gynecologist and Menopausal Patient Perspectives on Vaginal Hormone Therapy for the Management of the Genitourinary Syndrome of Menopause in Canada: A Real-World Survey.Patient Prefer Adherence2026https://conductscience.org/library/papers/42890743PubMed
42888352Population pharmacokinetic-pharmacodynamic modeling and dose selection of GS1-144 based on luteinizing hormone suppression in postmenopausal women.J Pharmacokinet Pharmacodyn2026https://conductscience.org/library/papers/42888352PubMed
42877707A comprehensive model for gynecologic cancer patients' survivorship care.Gynecol Oncol Rep2026https://conductscience.org/library/papers/42877707PubMed
42860281Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review.Womens Health Nurs2026https://conductscience.org/library/papers/42860281PubMed
42819486A mobile app compared with an educational pamphlet on menopause hormone therapy initiation: a randomized pilot study.Front Reprod Health2026https://conductscience.org/library/papers/42819486PubMed
42813007Menopause-associated gut microbiome remodeling and pharmacomicrobiomics: emerging mechanisms influencing drug response.Front Microbiomes2026https://conductscience.org/library/papers/42813007PubMed
42812512Assessing Vaginal Wall Elasticity via Shear-Wave Elastography Using a Transrectal Linear Array High-Frequency Probe in Premenopausal versus Postmenopausal Women: A Cross-Sectional Feasibility Study.Int J Womens Health2026https://conductscience.org/library/papers/42812512PubMed
42799440Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper.Glob Heart2026https://conductscience.org/library/papers/42799440PubMed

See all 316 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35797481

GET https://conductscience.org/api/papers/v1/35797481/cited_by?page=2